Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Jun 12, 2026, 4:00 PM EDT
1.650
+0.090 (5.77%)
Pre-market: Jun 15, 2026, 6:15 AM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $415.18 million as of June 15, 2026. Its market cap has decreased by -10.85% in one year.
Market Cap
415.18M
Enterprise Value
540.39M
1-Year Change
-10.85%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $415.18M, a decrease of -57.18%. That is a compound annual growth rate of -10.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 415.18M | -21.61% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 432.44M |
| C4 Therapeutics | 427.90M |
| Forte Biosciences | 425.18M |
| Ocugen | 413.00M |
| Ovid Therapeutics | 412.47M |
| Adlai Nortye | 408.00M |
| Prelude Therapeutics | 407.62M |
| Indaptus Therapeutics | 404.28M |